U.S. Markets open in 55 hrs, 36 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 16.85 03:32 PM EDT | |
|---|---|---|
| Day High | 17.90 09:30 AM EDT |
|
| Range | 1.05 |
| Volume | 578,222 | |
|---|---|---|
| 30-Day Avg Vol | 529,000 |
|
| Difference | 9.30% |
| Market Cap | 1.36 B | |
|---|---|---|
| Mkt Cap Chg | -87.30 M |
| Shares Out | 80.09 M | |
|---|---|---|
| % Shrs Traded | 0.72% | |
| 1yr EPS Est | -1.275 |
| 52-Wk Low | 11.81 3/12/09 | |
|---|---|---|
| 52-Wk High | 25.00 9/29/08 |
|
| Range | 13.19 |
| Prev Close | 18.14 7/1/09 | |
|---|---|---|
| Today's Open | 17.90 | |
| Change | -1.32% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.87 M |
| Revenue (LFY) | 238.45 M | |
|---|---|---|
| Earnings (LFY) | -82.71 M | |
| Earnings (MRQ) | -17.48 M | |
| Next Earn Est | -0.283 | |
| Next Earnings | 07/27/2009 |
|
| EPS (TTM) | -1.12 | |
| 1yr EPS Growth | -13.84% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -13.00 | |
| PEG Ratio | — | |
| Return on Equity | -18.95 | |
| Beta | 1.26 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Regeneron isn't the Pentagon, but the company is fighting some serious enemies. Regeneron Pharmaceuticals develops protein-based drugs used to battle a variety of diseases and conditions, including cancer, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.283 7/27/09 | — — |
—
—
|
| Last Quarter | -0.309 3/31/09 | -0.22 3/31/09 |
0.089
Beat
|
| 2 Quarters Ago | -0.301 12/31/08 | -0.40 12/31/08 |
-0.099
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 74.98 M | 238.46 M |
| Gross Profit | -7.56 M | -40.48 M |
| Operating Income | -19.23 M | -89.83 M |
| Net Income | -17.48 M | -82.71 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts